TCF4 and liposarcoma: The beta-catenin/TCF4 pathway also modifies alternative splicing through modulation of expression of splicing factors SRp20[72] and SF1[73] and direct interaction with FUS/TLS (translocated in liposarcoma) and various other RNA-binding proteins, including p54nrb[74].